Page last updated: 2024-12-06

solanidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

solanidine: derivative of DIOSGENIN that can rearrange to SOLANINE [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65727
CHEMBL ID1980466
CHEBI ID28374
SCHEMBL ID336752
MeSH IDM0060862

Synonyms (43)

Synonym
CHEBI:28374 ,
ccris 6508
solanid-5-en-3-ol, (3beta)-
22r,25s-solanidine
3-beta-solanid-5-en-3-ol
solanid-5-en-3-ol, (3-beta)-
solanid-5-en-3-beta-ol
brn 0045370
einecs 201-309-5
NCI60_041673
solanid-5-en-3beta-ol
LMST01150007
NSC76025 ,
nsc-76025
solatubine
solanid-5-en-3-ol, (3.beta.)-
solatubin
22r,25s-solanidanine
80-78-4
C06543
solanidine
w7801ohm8b ,
unii-w7801ohm8b
4-21-00-01398 (beilstein handbook reference)
solanidine [mi]
SCHEMBL336752
CHEMBL1980466
JVKYZPBMZPJNAJ-OQFNDJACSA-N
mfcd00056839
solanidine, >=97.0% (hplc)
solanid-5-en-3b-ol
solanid-5-en-3beta-ol(8ci)
solanid-5-en-3-ol (acd/name 4.0)
3-beta-solanid-5-en-3-ol(9cl)
3-b-solanid-5-en-3-ol(9cl)
Q3489153
CS-0111098
HY-N7271
DTXSID701018960
MS-26717
(1s,2s,7s,10r,11s,14s,15r,16s,17r,20s,23s)-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.02,11.05,10.015,23.017,22]tetracos-4-en-7-ol
gtpl12500
AKOS040738795

Research Excerpts

Overview

Solanidine is a steroidal aglycon of potato (Solanum tuberosum L.) glycoalkaloids. It is an important precursor for the synthesis of hormones and some pharmacologically active compounds.

ExcerptReferenceRelevance
"Solanidine is a steroidal aglycon of potato (Solanum tuberosum L.) glycoalkaloids and a very important precursor for the synthesis of hormones and some pharmacologically active compounds. "( Solanidine hydrolytic extraction and separation from the potato (Solanum tuberosum L.) vines by using solid-liquid-liquid systems.
Nikolic, NC; Stankovic, MZ, 2003
)
3.2

Effects

ExcerptReferenceRelevance
"3. Solanidine has been detected in human post-mortem liver and its identity confirmed by mass spectroscopy."( Kinetics and retention of solanidine in man.
Claringbold, WD; Few, JD; Renwick, JH, 1982
)
1.08

Dosage Studied

Mutation frequencies in the livers of the dams dosed with alpha-chaconine, alpha-solanine and solanidine were three to four times higher than historically normal. CYP2D6 PMs can easily be identified, hence facilitating the implementation of precision dosing in clinical practice.

ExcerptRelevanceReference
" The results of both positive and non-positive selection systems showed that the mutation frequencies in the livers of the dams dosed with alpha-chaconine, alpha-solanine and solanidine were three to four times higher than historically normal in the livers of this transgenic mouse strain."( A preliminary assessment of the toxic and mutagenic potential of steroidal alkaloids in transgenic mice.
Crawford, L; Myhr, B, 1995
)
0.48
"Poor metabolizers (PMs) of the highly polymorphic enzyme CYP2D6 are usually at high risk of adverse effects during standard recommended dosing of CYP2D6-metabolized drugs."( Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype.
Kringen, MK; Molden, E; Smith, RL; Størset, E; Wollmann, BM, 2023
)
1.15
" By measuring solanidine and metabolites using liquid chromatography-mass spectrometry in patient serum samples, CYP2D6 PMs can easily be identified, hence facilitating the implementation of precision dosing in clinical practice."( Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype.
Kringen, MK; Molden, E; Smith, RL; Størset, E; Wollmann, BM, 2023
)
1.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
toxinPoisonous substance produced by a biological organism such as a microbe, animal or plant.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
steroid alkaloid fundamental parent
3beta-hydroxy-Delta(5)-steroidAny 3beta-hydroxy-steroid that contains a double bond between positions 5 and 6.
solanid-5-en-3-olA 3-hydroxy steroid that is solanid-5-ene substituted by a hydroxy group at position 3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
u03B1-solanine/u03B1-chaconine biosynthesis38

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1323480Inhibition of hedgehog signaling pathway in mouse Shh Light2 cells assessed as inhibition of sonic hedgehog-induced GLI1-mediated transcriptional activity measured after 30 hrs by dual luciferase reporter gene assay2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
Three new alkaloids from Veratrum grandiflorum Loes with inhibition activities on Hedgehog pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (22.22)18.7374
1990's9 (16.67)18.2507
2000's10 (18.52)29.6817
2010's20 (37.04)24.3611
2020's3 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.45 (24.57)
Research Supply Index4.06 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (10.53%)6.00%
Case Studies1 (1.75%)4.05%
Observational0 (0.00%)0.25%
Other50 (87.72%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]